DrillishCGirkeW. Ergebnisse der Behendlung von Migraene-Patienten mit Cinnarizin und Flunarizin. Med Welt1980;31:1870–7.
2.
LouisP. A double-blind placebo controlled prophylactic study of flunarizine (SIBELIUM) in migraine. Headache1981;25:235–41.
3.
LouisPSpieringsELH. Comparison of flunarizine (SIBELIUM) and pizotifene (SANDOMIGRAN) in migraine treatment: a double-blind study. Cephalalgia1982;2:197–203.
4.
AmeryWK. Flunarizine, a calcium channel blocker: a new prophylactic drug in migraine. 24th Annual Meeting of the American Association for the Study of Headache, New Orleans, 1982.
5.
AmeryWKWauquierAVan NeutenJMDe ClerckFVan ReemptsJVJanssenPAJ. The anti-migrainous pharmacology of flunarizine (R 14950), a calcium antagonist. Drug Exp Clin Res1981;7:1–12.
6.
DiamondSSchembaumH. Flunarizine, a calcium channel blocker in the prophylactic treatment of migraine. Headache1983;23:39–44.
7.
MicieliGPacchettiCSancesGSinforianiETruccoMMagriM. La Flunarizina nella profilassi della emicrania comune. Farmaci1984;8:67–73.
8.
CentonzeVSantoiemmaLMacinagrossaGAltomareEMagroneDTrizioTAlbanoO. Flunarizine versus Verapamil in the prophylactic treatment of migraine. Abs. 1st Congress of the Mediterranean Society of Therapy, Florence, 1984;48:153.
9.
OlesenJTfelt-HansenPHenriksenLLarsenB. The common migraine attack may not be initiated by cerebral ischaemia. Lancet1981;2:438–40.
10.
CentonzeVAttoliniEBozzaniAMacinagrossaGSantoiemmaLBrucoliCLoisyCAlbanoO. Hypoxia in the pathogenesis of migraine attacks. In: Clifford RoseFAmeryWK eds Cerebral hypoxia in the pathogenesis of migraine1982;19:132–5.
11.
AmeryWK. Brain hypoxia: the turning-point in the genesis of migraine attacks. Cephalalgia1982;2:83–109.
12.
CentonzeVAmatGLoisyCVenaGPelageS. Considérations sur les accidents vasculaires cérèbraux chez les migraineux. Sem Hop Paris1980;56:1908–10.
13.
OlesenJLarsenB. Cerebral blood flow in migraine. Is ischemia involved? In: Clifford RoseFAmeryWK eds Cerebral hypoxia in the pathogenesis of migraine, 1982;9:53–73.
14.
SpieringsELH. Arterial vasoconstriction versus arterio-venous shunting in the migraine aura. In: Clifford RoseFAmeryWK eds Cerebral hypoxia in the pathogenesis of migraine, 1982;9:12–22.
15.
MathewNT. Cerebral blood flow in migraineurs. In: Clifford RoseFAmeryWK eds Cerebral hypoxia in the pathogenesis of migraine, 1982;6:39–41.
16.
BorgersMXhonneuxR. Profile and selectivity of the action of flunarizine. International Symposium on Sibelium, Istambul, 1982.
17.
GodfraindT. Influence du vieillissement sur le relâ-chement bêta-adrenergique de l'aorte de rat traitée par la flunarizine. Journal de Pharmacologie1978;9:178–84.
18.
HayDWPWadsworthRM. A comparison of the effects of some calcium antagonists on drug-induced rhythmic contraction of the rat vas deferens. Br J Pharmacol1981;72:563–8.
19.
GreeneMABoltaxAJLustigGARogowE. Circulatory dynamics during the cold pressor test. Am J Cardiol1965;16:54–60.
20.
GoddenJORothGMHinesEA. The changes in the intra-arterial pressure during immersion of the hand in ice cold water. Circulation1955;12:963–73.
21.
VoudoukisIJ. Cold pressor test and hypertension. In: Acts of 19th Annual Meeting of the International College of Angiology, Dublin, Ireland, May 15-19, 1977.
22.
ChaikinP. A clinical evaluation of the pharmacokinetics and pharmacologic effects of flunarizine on myocardial conduction: a single blind, multiple dose study. Ortho Pharm, April 1982.
23.
ChaikinP. The pharmacokinetics of single doses of flunarizine in normal volunteers. Ortho Pharm, April 1982.
24.
NakayamaKKasuyaY. Selective abolition of Cadependent responses of smooth and cardiac muscles by flunarizine. Jpn J Pharmacol1980;30:731–7.
25.
Van NeutenJMVan BeekJJanssenPAJ. The vascular effects of flunarizine as compared with those of other clinically used vasoactive substances. Arzneim Forsch1978;28:2082–6.
26.
ArrigoALotticiPAlfonsiETerraneoGB. Flunarizina ed insufficienza cerebro-vascolare. Clin Ter1984;110:541–8.